A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Neuro Oncol
; 16(1): 92-102, 2014 Jan.
Article
in En
| MEDLINE
| ID: mdl-24311637
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrroles
/
Brain Neoplasms
/
Glioblastoma
/
Angiogenesis Inhibitors
/
Indoles
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Neuro Oncol
Journal subject:
NEOPLASIAS
/
NEUROLOGIA
Year:
2014
Type:
Article
Affiliation country:
Germany